Difference between revisions of "Sancak Y, et al. Mol. Cell (2007) cited as Ref 357 in DOI: 10.1038/s41392-020-0110-5 (Q9620)"

@@ Property / DOI Identifier @@
+.1016/j.molcel.2007.03.003
@@ Property / DOI Identifier: 10.1016/j.molcel.2007.03.003 / rank @@
+Normal rank
@@ Property / PubMed ID @@
+17386266
@@ Property / PubMed ID: 17386266 / rank @@
+Normal rank
@@ Property / Publication Date @@
+Timestamp +2007-01-01T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 year
Before 0
After 0
-Timestamp
++2007-01-01T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+year
 Before
 After
@@ Property / Publication Date: 2007 / rank @@
+Normal rank
@@ Property / Published In Name String @@
+Mol. Cell
@@ Property / Published In Name String: Mol. Cell / rank @@
+Normal rank
@@ Property / Volume @@
@@ Property / Volume: 25 / rank @@
+Normal rank
@@ Property / title @@
+PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase (English)
+Normal rank
@@ Property / Page(s) @@
+-915
@@ Property / Page(s): 903-915 / rank @@
+Normal rank

Latest revision as of 15:38, 21 May 2020

Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

Language	Label	Description	Also known as
English	Sancak Y, et al. Mol. Cell (2007) cited as Ref 357 in DOI: 10.1038/s41392-020-0110-5	Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8